One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes-Reference-Cited by-同舟云学术

One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes

Published:2024-05 Issue:10 Volume:20 Page:e630-e642
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Cao Davide,Vranckx Pascal,Valgimigli Marco,Sartori Samantha,Angiolillo Dominick J.,Bangalore Sripal,Bhatt Deepak L.,Feng Yihan,Ge Junbo,Hermiller James,Makkar Raj R.,Neumann Franz-Josef,Saito Shigeru,Picon Hector,Toelg Ralph,Maksoud Aziz,Chehab Bassem M.,Choi James W.,Campo Gianluca,De la Torre Hernandez José M.,Krucoff Mitchell W.,Kunadian Vijay,Sardella Gennaro,Spirito Alessandro,Thiele Holger,Varenne Olivier,Vogel Birgit,Zhou Yujie,Windecker Stephan,Mehran Roxana

Publisher

Europa Digital & Publishing

Reference33 articles.

1. Recognized Outstanding Reviewers for Circulation in 2021

2. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

4. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis

5. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can DAPT be discontinued at one month after PCI in high bleeding risk patients presenting with ACS?;EuroIntervention;2024-05